×
About 131,005 results

ALLMedicine™ Hepatitis Center

Research & Reviews  42,282 results

Performance of rapid test for antibodies to hepatitis C virus (anti-HCV) in hemodialysi...
https://doi.org/10.1177/03913988221104834
The International Journal of Artificial Organs; Becker SCDC, Medina-Pestana JO et. al.

Jun 26th, 2022 - Rapid tests (RT) have been widely used for screening of hepatitis C virus (HCV) in general population, but its performance in hemodialysis (HD) patients and mainly in kidney-transplant recipients (RTx) is less known. The aim of this study was to e...

Xyloketal B Reverses Nutritional Hepatic Steatosis, Steatohepatitis, and Liver Fibrosis...
https://doi.org/10.1021/acs.jnatprod.2c00259
Journal of Natural Products; Tong Y, Zhu W et. al.

Jun 25th, 2022 - Nonalcoholic fatty liver disease (NAFLD) represents a class of disorders including hepatic steatosis, steatohepatitis, and liver fibrosis. Previous research suggested that xyloketal B (Xyl-B), a marine-derived natural product, could attenuate the ...

Treatment of Hepatitis Delta and HIV Infection.
https://doi.org/10.1111/liv.15345
Liver International : Official Journal of the Internation... Soriano V, de Mendoza C et. al.

Jun 25th, 2022 - Hepatitis delta virus (HDV) is a defective agent that only infects individuals with hepatitis B virus (HBV). Around 5-10% of chronic hepatitis B patients worldwide are superinfected with HDV, which means 15-25 million people. Hepatitis delta is th...

Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time t...
https://doi.org/10.1111/apt.17069
Alimentary Pharmacology & Therapeutics; Ko KL, Hung IF et. al.

Jun 25th, 2022 - Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game. Authors' reply.|2022|Ko KL,Hung IF,Leung WK,|

Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time t...
https://doi.org/10.1111/apt.17044
Alimentary Pharmacology & Therapeutics; Gill M, Majumdar A

Jun 25th, 2022 - Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game.|2022|Gill M,Majumdar A,|

see more →

Guidelines  105 results

KASL clinical practice guidelines for management of chronic hepatitis B.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013624
Clinical and Molecular Hepatology;

Apr 18th, 2022 - KASL clinical practice guidelines for management of chronic hepatitis B.|2022| ,|therapeutic use,genetics,drug therapy,

Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979596
MMWR. Morbidity and Mortality Weekly Report; Weng MK, Doshani M et. al.

Apr 1st, 2022 - Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in...

Best practice guidelines for France regarding the diagnosis and management of autoimmun...
https://doi.org/10.1016/j.clinre.2022.101871
Clinics and Research in Hepatology and Gastroenterology; Duclos-Vallée JC, Debray D et. al.

Feb 3rd, 2022 - Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.|2022|Duclos-Vallée JC,Debray D,De Martin E,Beux EL,Louvet A,|diagnosis,drug therapy,pathology,pathology,

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS B VIRUS.
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Non-invasive diagnosis and follow-up of autoimmune hepatitis.
https://doi.org/10.1016/j.clinre.2021.101772
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.

Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...

see more →

Drugs  425 results see all →

Clinicaltrials.gov  4,489 results

Screening Protocol for the Evaluation of Potential Research Subjects
https://clinicaltrials.gov/ct2/show/NCT01036971

Jun 24th, 2022 - This protocol describes the screening process used by the National Institute on Drug Abuse (NIDA IRP) to assess potential research participants' eligibility for entering protocols of the NIDA/IRP. Through its clinical research protocols, the IRP a...

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
https://clinicaltrials.gov/ct2/show/NCT01011712

Jun 24th, 2022 - Viral infections in the normal host are usually self-limited as the innate and acquired immune systems mount successful antiviral responses. However, in some instances, apparently immunocompetent persons manifest infections with viruses that would...

Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick
https://clinicaltrials.gov/ct2/show/NCT00339911

Jun 24th, 2022 - Background -NCI-Frederick scientists performing in vitro studies involving human specimens have a need for a reliable and consistent source of samples which protects the donor from research risks. Objective -The purpose of this protocol is to esta...

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
https://clinicaltrials.gov/ct2/show/NCT03520660

Jun 24th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...

Seroprevalence of Hepatitis E in People With an Organ Transplant
https://clinicaltrials.gov/ct2/show/NCT02190253

Jun 24th, 2022 - Hepatitis E virus infection commonly presents as an acute self-limiting hepatitis in the developing world. However there have been reports that chronic hepatitis E may develop in immunocompromised subjects such as renal and liver transplant recipi...

see more →

News  5,015 results

Acute Hepatitis Cases in Children Show Declining Trend; Adenovirus, COVID-19 Remain Key Leads
https://www.medscape.com/viewarticle/976174

Jun 24th, 2022 - LONDON ― Case numbers of acute hepatitis in children show "a declining trajectory," and COVID-19 and adenovirus remain the most likely, but as yet unproven, causative agents, said experts in an update at the International Liver Congress (ILC) 2022...

CDC Releases New Details on Mysterious Hepatitis in Children
https://www.medscape.com/viewarticle/976200

Jun 24th, 2022 - A new analysis from the Centers for Disease Control and Prevention (CDC) provides further details on mysterious cases of pediatric hepatitis identified across the United States. While 45% percent of patients have tested positive for adenovirus inf...

Autoimmune disorder drugs top list of meds linked to headache
https://www.mdedge.com/neurology/article/255727/headache-migraine/autoimmune-disorder-drugs-top-list-meds-linked-headache
Randy Dotinga

Jun 23rd, 2022 - DENVER – Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in a federal side effect database that anyone can contribute to, ac.

Top Medications Most Often Linked to Headache
https://www.medscape.com/viewarticle/976124

Jun 23rd, 2022 - DENVER, Colorado — Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in a federal side effect database that anyone can contrib...

Alcoholic Cirrhosis Is Most Common Liver Transplant Indication in Young US Adults
https://www.medscape.com/viewarticle/975925

Jun 22nd, 2022 - NEW YORK (Reuters Health) - Alcohol-associated liver disease is now the most common indication for liver transplant wait-listing among young American adults, researchers say. From 2003 to 2018, the diagnosis of alcoholic liver disease (ALD) as an ...

see more →

Patient Education  86 results see all →